Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from Accesswire

04:13 EDT 24th August 2019 | BioPortfolio

Here are the most relevant search results for "Accesswire" found in our extensive news archives from over 250 global news sources.

More Information about Accesswire on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Accesswire for you to read. Along with our medical data and news we also list Accesswire Clinical Trials, which are updated daily. BioPortfolio also has a large database of Accesswire Companies for you to search.

Showing News Articles 1–25 of 777 from Accesswire

Thursday 22nd August 2019

LED Medical Diagnostics Inc. Reports 2019 Second Quarter Results

VANCOUVER, BC / ACCESSWIRE / August 22, 2019 / LED Medical Diagnostics Inc. (TSXV:LMD)(OTCQB:LEDIF) ("LED" or the "Company"), a leading dental imaging technology provider focused on delivering state-of-the-art imaging software and systems, today announced its financial results for the second quarter ended June 30, 2019, reported in United States dollars and in accordance with International Financ...

Ventura Cannabis (VCAN) Gets Conditional Regulatory Approval to Close Kush Rush Acquisition 

Not For Distribution To United States Newswire Services Or For Dissemination In The United States. All Figures In Canadian Dollars Unless Otherwise Specified. LOS ANGELES, CA / ACCESSWIRE / August 22, 2019 / Ventura Cannabis and Wellness Corp. (CSE:VCAN) (“Ventura Cannabis”, “VCAN”, or the “Company”) is pleased to announce it has received conditional regulatory approval from the Burea...

Theralase Announces Closing of Prospectus Offering for Gross Proceeds of $17,250,000

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, ON / ACCESSWIRE / August 22, 2019 / Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV: TLT) (OTCQB: TLTFF), is pleased to announce the closing of its marketed short form prospectus offering pursuant to which the Company issued 57,500,000 units of the Company (including t...

Jaguar Health Subsidiary Napo Pharmaceuticals to Host Facebook Live "HIV Community Conversation" Event with HIV Advocate Kamaria Laffrey August 23, 2019 at 3 p.m. Eastern

SAN FRANCISCO, CA / ACCESSWIRE / August 22, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), today announced that the Company’s wholly-owned, human-health focused subsidiary, Napo Pharmaceuticals, Inc. (“Napo”), is hosting a Facebook Live conversation at 3 p.m. Eastern tomorrow, August 23, 2019, between Josh Robbins and Kamaria Laffrey, a prominent HIV advocate, ...

ReShape Lifesciences(TM) to Highlight Products at IFSO 24th World Congress

SAN CLEMENTE, CA / ACCESSWIRE / August 22, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that the Company will be attending the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) World Congress, taking place at Ifema Palacio Municipal in Madrid, Spain, from Se...

Viveve Signs Exclusive Distribution Partnership in Canada with Salient Medical Solutions

Company Expands North America Commercial Capabilities ENGLEWOOD, CO / ACCESSWIRE / August 22, 2019 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced an exclusive distribution agreement with Salient Medical Solutions, a leading distributor of innovative world-class medical devices and technologies in Canada. “We are pleased ...

American CryoStem Engages IRB for IND Filling with the FDA

EATONTOWN, NJ / ACCESSWIRE / August 22, 2019 / American CryoStem Corporation (OTC PINK:CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular products and technologies for the Regenerative and Personalized Medicine industries, today announced that it has engaged The Institute of Regenerative Cellular Medicine (IRCM) www.ircm.org to perform the I...

Wednesday 21st August 2019

Dyadic to Present at Four Upcoming Investor Conferences in September

JUPITER, FL / ACCESSWIRE / August 21, 2019 / Dyadic International, Inc. (the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to speed up the development, lower production costs and improve the performance of biologic vaccines, drugs, and other biologic products, at flexible commercial scales, today annou...

Perimeter Medical Imaging Closes Oversubscribed $C4.4M Financing

TORONTO, ON / ACCESSWIRE / August 21, 2019 / Perimeter Medical Imaging, Inc., the leader in real-time tissue imaging in the operating suite is pleased to announce the completion of a pre-public financing round raising $C4.4million. Perimeter intends to go public via a reverse takeover (RTO) with New World Resources (NW) in Q4 of this year. Funds raised in this pre-public round and anticipated RTO ...

ENDRA Life Sciences to Participate at Upcoming Investor Conferences

ANN ARBOR, MI / ACCESSWIRE / August 21, 2019 / ENDRA Life Sciences Inc.(“ENDRA”) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that management will participate in the following investor conferences during the month of September: Dougherty & Company 2019 Institutional Investor Conference Attendees: Francois Michelon, Chief Executive Officer an...

Pure Ratios Releases New CBD Capsule Line

Pure Ratios Holdings, a subsidiary of 4Front Ventures Corp (CSE:FFNT.CN)(OTCQX:FFNTF), unveils the release of Pure Ratios Essentials: a new line of CBD capsules formulated with adaptogenic* herbs and mushrooms in four innovative directions. SAN DIEGO, CA / ACCESSWIRE / August 21, 2019 / Pure Ratios proudly announces the release of their new adaptogenic* CBD capsule line in four distinct formulati...

Tuesday 20th August 2019

Enlighta and LHHC Enter Strategic Agreement for AI Big Data Cancer Diagnostics

‘No Cancer’ AI and big data for individuals of Asian descent uses routine blood tests for early detection or 13 cancers VANCOUVER, BC / ACCESSWIRE / August 20, 2019 / Enlighta Inc. (“Enlighta” or the “Company”) (TSXV:NLTA), is pleased to announce a strategic cooperation with LHHC Medical Technology Corp. (“LHHC”) to globally market a ‘No Cancer’ big data artificial intelligenc...

Hancock Jaffe Successfully Completes Two Additional VenoValve Implantations for First-in-Man Study

Eight Patients Now Part of First-in-Man Bogota Study IRVINE, CA / ACCESSWIRE / August 20, 2019 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI, HJLIW), a developer of medical devices that restore cardiac and vascular health, has successfully implanted VenoValves in two additional patients, as part of HJLI’s first-in-man Bogota study. Eight patients have now received VenoValves as part of the in...

Jaguar Health Subsidiary Napo Pharmaceuticals Appoints Brian Sutton National Business Director

SAN FRANCISCO, CA / ACCESSWIRE / August 20, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), a commercial stage pharmaceutical company focused on developing novel, sustainably derived gastrointestinal products on a global basis, announced today that the Company’s wholly-owned, human-health focused subsidiary, Napo Pharmaceuticals, Inc. (“Napo”), has promoted Bria...

GT Biopharma Hires Chief Medical Officer Jeffery Miller, M.D.

TAMPA, FL / ACCESSWIRE / August 20, 2019 / GT Biopharma, Inc. (OTCQB:GTBP) (GTBP.PA) an immuno-oncology company focused on innovative treatments based on the Company's proprietary NK cell engager (TriKE™) platform and Multi-Target Directed Bispecific Drug Conjugate platform, announced today that Jeffrey Miller, M.D. has been hired by the Company as its Consulting Chief Medical Officer. Dr. Mill...

Itoco Completes Review Of Best-Practice Technologies And Methodologies For High-Quality CBD Oil Extraction

TORONTO, CANADA / ACCESSWIRE / August 20, 2019 / ITOCO Inc. ("ITOCO" or the "Company") (OTC PINK:ITMC) is pleased to announce that it has recently completed a review of the state of the art for technologies and methodologies as it pertains to extracting CBD oil from Cannabis plant matter. The subjects of this review ranged from solvents and temperatures to use in the initial extraction wash, to d...

Monday 19th August 2019

ADM Tronics Reports First Quarter of Fiscal Year 2020 Results

NORTHVALE, NJ / ACCESSWIRE / August 19, 2019 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for its first fiscal quarter ended June 30, 2019 of Fiscal Year 2020. During the quarter ended June 30, 2019 there was an increase in revenues as ADMT began to fulfill the customer order backlog of $...

Advanzeon Solutions, Inc.'s Wholly Owned Subsidiary, Pharmacy Value Management Solutions, Inc., Announces Strategic Relationship with Crank Communications

TAMPA, FL / ACCESSWIRE / August 19, 2019 / Advanzeon Solutions, Inc. (OTC PINK:CHCR)(“Advanzeon”) announced today that its wholly-owned subsidiary, Pharmacy Value Management Solutions, Inc. (collectively, the “Company”), has formed a strategic relationship with Crank Communications. Crank Communications, a leader in marketing, advertising and public relations, has been retained by the Co...

Jaguar Health Achieves Statistically Significant Top Line Results in Study Evaluating Crofelemer for Treatment of Diarrhea Related to Targeted Cancer Therapy

Preclinical Study Results Expected to Provide Key Supportive Data for Future Clinical Investigations Evaluating Crofelemer for Treatment of Noninfectious Diarrhea in Human Cancer Patients Receiving Targeted Cancer Therapy SAN FRANCISCO, CA / ACCESSWIRE / August 19, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”) announced today that statistically significant top line ...

Avinger Announces Presentations by Key Opinion Leaders at AMP 2019 Clinical Conference

REDWOOD, CA / ACCESSWIRE / August 19, 2019 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for the diagnosis and treatment of Peripheral Artery Disease (PAD), today announced four podium presentations featuring the Company’s Lumivascular technology at the annual AMP (Amputation Prevention Symp...

Friday 16th August 2019

Oncolytics Biotech(R) Announces Closing of Its Public Offering of Common Shares and Warrants

SAN DIEGO, CA and CALGARY, AB / ACCESSWIRE / August 16, 2019 / Oncolytics Biotech® Inc. (NASDAQ:ONCY)(TSX:ONC) (the “Company”), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus, today announced the closing of its previously announced underwritten public offering (the “Offering”). Oncolytics sold 4,619,773 common shares and warrants to purchase up to 4,619...

Jaguar Health Appoints Carol Lizak Chief Accounting Officer

SAN FRANCISCO, CA / ACCESSWIRE / August 16, 2019 / Jaguar Health, Inc. (NASDAQ:JAGX) (“Jaguar” or the “Company”), a commercial stage pharmaceutical company focused on developing novel, sustainably derived gastrointestinal products on a global basis, announced today that the Company has promoted Carol Lizak to the role of chief accounting officer for Jaguar. Lizak formerly served as Jaguar...

Thursday 15th August 2019

Intellipharmaceutics Signs an Exclusive License and Commercial Supply Agreement with Tris Pharma, Inc.

TORONTO, ON / ACCESSWIRE / August 15, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, announced today that it has entered into a license and commercial s...

Pressure BioSciences, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update

Record Consumables Sales, Strong Growth in BaroFold & UST Services, and Launch of Revolutionary CBD Processing System Highlight the 2019 Second Quarter; Company Believes Total Revenue Will More than Double in 2020 Investor Conference Call Scheduled for Thursday, August 15, 2019 at 4:30 PM EDT SOUTH EASTON, MA / ACCESSWIRE / August 15, 2019 / Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” or...

MobileSmith Health Announces New Addition to Executive Team

Industry veteran Bruce Kennedy joins the digital health and mobile development leader as Vice President of Provider Development


Quick Search

News Quicklinks